Dr. Wilky  is the Director of Sarcoma Medical Oncology at the University of Colorado. She cares for patients over the age of 18 with every type of sarcoma and is an expert not only in traditional chemotherapy treatments for sarcomas, but also at using modern technology such as gene sequencing and molecular profiling to identify out-of-the-box treatments particularly in targeted therapy.  Dr. Wilky is also a translational researcher who conducts and designs clinical trials for sarcoma patients, with a focus on early immunotherapy protocols.  Her laboratory studies the interaction between sarcomas and the immune system. Additionally, Dr. Wilky leads the investigator-initiated clinical trials committee at the University of Colorado Cancer Center, helping other researchers bring laboratory science discoveries into human clinical trials

You can get so much great information about sarcoma and treatments by following Dr. Wilky on social media on Twitter or on her blog

In this episode we discuss:

• How are clinical trials used in medicine
• The hope of clinical trials
• Phase 1 clinical trials
• Phase 2 and 3 clinical trials 
• Learning from all patients enrolled on clinical trials
• Big data and sarcoma
• Immunotherapy and sarcoma
• Compassionate use and right to try
• What are the most important questions you should ask your doctor when considering a clinical trial 

music: Rospigg

photo credit: volodymyr-hrysh